Source: Υπουργείο Υγείας (CY) Revision Year: 2017 Publisher: Medochemie Ltd, 1-10 Constantinoupoleos Street 3011, Cyprus
Klont 200 mg tablets.
Pharmaceutical Form |
---|
Immediate release tablets. Klont 200 mg tablets are flat, round, orange, scored tablets, with a diameter of 12.7 mm. |
Each tablet contains metronidazole 200 mg.
Excipients with known effect: lactose monohydrate (265 mg/tablet), tartrazine (E102) and sunset yellow (E110).
For the full list of excipients see section 6.1.
Active Ingredient | Description | |
---|---|---|
Methronidazole |
Metronidazole is an anti-infectious drug belonging to the pharmacotherapeutic group of nitroimidazole derivatives, which have effect mainly on strict anaerobes. This effect is probably caused by interaction with DNS and different metabolites. |
List of Excipients |
---|
Povidone K25 |
Polyvinylchloride film-aluminium foil blisters, with a patient information leaflet, in a card carton.
Cartons containing 20, 50, 60 and 100 tablets are available.
Polyvinylchloride securitainers with tamper evident closure, packs containing 100, 250, 500, and 1000 tablets are available.
Not all pack sizes may be marketed.
Medochemie Ltd, 1-10 Constantinoupoleos Street 3011, Cyprus
17680
02.04.1998 / 24.11.2009
Drug | Countries | |
---|---|---|
KLONT | Cyprus, Hong Kong, Malta |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.